Bajaj Healthcare enters into development and supply agreement with European Entity

23 Sep 2024 Evaluate

Bajaj Healthcare has entered into a development and supply agreement for an Active Pharmaceutical Ingredient (API) with a European Entity. This API after its development will be initially supplied in small quantities and will be used by the EU partner to carry out clinical trials for an alternative indication.

The trust reposed in the company by the EU partner for sourcing clinical trial quantities is a testimony of the company’s development and manufacturing capabilities along with the Good Manufacturing Practices (GMP) compliance at company’s manufacturing units.

Based on the outcome of these trials, the supplies will be done from the company’s FDA approved manufacturing facility situated at Savli, Vadodara. Further, till the outcome of these trials, it will be revenue neutral.

Bajaj Healthcare mainly focuses on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries.


Bajaj Healthcare Share Price

559.00 89.90 (19.16%)
18-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.30
Dr. Reddys Lab 1275.05
Cipla 1472.05
Lupin 2098.70
Zydus Lifesciences 979.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.